VITILIGO

This study tested whether a drug called apremilast, combined with UVB light therapy, can help restore skin color in people with vitiligo. Eighty adults with vitiligo covering at least 10% of their body took part. The goal was to see if the combination works better than light ther…

This study tested a drug called AMG 714 in 60 adults with vitiligo, a condition that causes white patches on the skin. The goal was to see if it could improve skin color on the face after 24 weeks. Participants received either the drug or a placebo, and all underwent light therap…

This study tested whether adding methotrexate (a medication) to UVB light therapy helps adults with active, widespread vitiligo regain skin color. 32 participants were randomly assigned to receive either the combination or light therapy alone. The main goal was to measure changes…

This study tested whether adding baricitinib (a pill) to standard light therapy works better than light therapy alone for adults with active, spreading vitiligo. 49 participants were followed for 12 weeks to measure changes in skin color using a scoring tool. The goal was to see …

This study tested whether adding the cholesterol-lowering drug atorvastatin to standard UVB light therapy works better than light therapy alone for adults with active vitiligo. 28 people took part over 6 months. The goal was to see if the combination could reduce the amount of sk…

This study tested whether starting treatment very early in vitiligo can stop the disease from spreading and improve skin color return. 51 people with different stages of vitiligo received a combination of light therapy and low-dose steroids for 6 months. The goal was to see if th…

This study tested whether adding an oral antioxidant (GLISODIN) to standard UVB light therapy helps treat vitiligo better than light therapy alone. 50 adults with non-segmental vitiligo covering more than 5% of their body took part. The main goal was to measure changes in skin co…

This study tested whether using ruxolitinib alone or combined with other creams (tacrolimus or steroids) works better for vitiligo. 120 adults with limited skin involvement were treated for 24 weeks. The goal was to see which approach restores more skin color safely.

This study tested whether tofacitinib, a drug already approved for other conditions, is safe and helpful for people with Down syndrome who also have immune-related skin problems like eczema, psoriasis, or hair loss. The study included 47 adolescents and adults. Researchers measur…

This study tested two light therapies—blue light and targeted UVB—to see which helps restore skin color better in people with stable vitiligo. Thirty adults with small, stable patches of vitiligo took part. The goal was to measure how much the patches improved after treatment.…

This study looked at why vitiligo repigmentation varies by body location, such as the face responding better than hands. Researchers compared skin samples from 20 people with vitiligo and healthy volunteers to understand the genetic factors involved. The goal was to learn more ab…

This study looked at over 36,000 adults in the UK to see if people with vitiligo are more likely to have mental health problems like depression and anxiety. Researchers compared people with vitiligo to similar people without it. The goal was to understand the mental health risks …

This study tested specially engineered versions of a natural immune protein (IL-2) in blood samples from 67 people with autoimmune or inflammatory diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal was to see if these modified proteins could selectively a…